Endothelix, Inc. is a cardiovascular device company based in Houston, Texas and is focused on non-invasive vascular function measurement. The company originated from the Texas Medical Center-Houston from a collaborative project between the Texas Heart Institute and The University of Texas Health Science Center at Houston. Endothelix received a $1 million award from the Texas Emerging Technology Fund to develop the VENDYS^® technology.

Endothelix’s first product is VENDYS^®, a non-invasive, inexpensive, and easy to use vascular function test. VENDYS^® is FDA approved and is currently marketed throughout the United States, Europe and Canada. The company has a pipeline of innovative products.

Website: www.endothelix.com